Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639281 | 12663928 | 1 | I | 20160424 | 20160810 | 20160818 | 20160818 | EXP | CN-PFIZER INC-2016388594 | PFIZER | 75.00 | YR | F | Y | 62.00000 | KG | 20160818 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639281 | 12663928 | 1 | PS | CELECOXIB. | CELECOXIB | 1 | Oral | 0.2 G, 2X/DAY | 1.6670001 | G | Y | N07163 | 20998 | .2 | G | CAPSULE, HARD | BID | ||
| 126639281 | 12663928 | 2 | SS | ETHAMBUTOL HYDROCHLORIDE. | ETHAMBUTOL HYDROCHLORIDE | 1 | Oral | 0.75 G, DAILY | Y | 1510081 | 0 | .75 | G | TABLET | |||||
| 126639281 | 12663928 | 3 | SS | RIFAPENTINE | RIFAPENTINE | 1 | 0.45 G, EVERY 7 DAYS | 1 | G | Y | 20150909 | 0 | .45 | G | CAPSULE | /wk | |||
| 126639281 | 12663928 | 4 | SS | AMINOSALICYLATE SODIUM W/ISONIAZID | AMINOSALICYLATE SODIUMISONIAZID | 1 | Oral | 0.3 G, 3X/DAY | 6.125 | G | Y | 01151124 | 0 | .3 | G | TABLET | TID | ||
| 126639281 | 12663928 | 5 | C | SILYBIN MEGLUMINE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126639281 | 12663928 | 1 | Rheumatoid arthritis |
| 126639281 | 12663928 | 2 | Pulmonary tuberculosis |
| 126639281 | 12663928 | 3 | Pulmonary tuberculosis |
| 126639281 | 12663928 | 4 | Pulmonary tuberculosis |
| 126639281 | 12663928 | 5 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126639281 | 12663928 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126639281 | 12663928 | Alanine aminotransferase increased | |
| 126639281 | 12663928 | Aspartate aminotransferase increased | |
| 126639281 | 12663928 | Asthenia | |
| 126639281 | 12663928 | Decreased appetite | |
| 126639281 | 12663928 | Hepatic function abnormal | |
| 126639281 | 12663928 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126639281 | 12663928 | 1 | 20160420 | 20160425 | 0 | |
| 126639281 | 12663928 | 2 | 20160418 | 20160425 | 0 | |
| 126639281 | 12663928 | 3 | 20160418 | 20160424 | 0 | |
| 126639281 | 12663928 | 4 | 20160418 | 20160425 | 0 |